BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsonii La1. ✅
The British journal of nutrition (Br J Nutr ) Vol: 95 Issue 2 Pages: 303-12 Pub: 2006 Feb Epub: Authors Yamano T , Iino H , Takada M , Blum S , Rochat F , Fukushima Y , |
|
|
Probiotic Lactobacillus johnsonii BS15 Promotes Growth Performance, Intestinal Immunity, and Gut Microbiota in Piglets. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 12 Issue 1 Pages: 184-193 Pub: 2020 Mar Epub: Authors Xin J , Zeng D , Wang H , Sun N , Zhao Y , Dan Y , Pan K , Jing B , Ni X , |
|
|
Live Probiotic Lactobacillus johnsonii BS15 Promotes Growth Performance and Lowers Fat Deposition by Improving Lipid Metabolism, Intestinal Development, and Gut Microflora in Broilers. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 8 Issue Pages: 1073 Pub: 2017 Epub: 2017 Jun 12 Authors Wang H , Ni X , Qing X , Zeng D , Luo M , Liu L , Li G , Pan K , Jing B , |
|
|
Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. ✅
FEMS microbiology letters (FEMS Microbiol Lett ) Vol: 248 Issue 2 Pages: 249-56 Pub: 2005 Jul 15 Epub: Authors Garrido D , Suau A , Pochart P , Cruchet S , Gotteland M , |
|
|
Probiotic Lactobacilli Administration Induces Changes in the Fecal Microbiota of Preweaned Dairy Calves. ✅
Go to Publication ✅
Probiotics and antimicrobial proteins (Probiotics Antimicrob Proteins ) Vol: 14 Issue 5 Pages: 804-815 Pub: 2022 Oct Epub: 2021 Aug 14 Authors Fernández-Ciganda S , Fraga M , Zunino P , |
|
|
Cell-free supernatant of probiotic bacteria exerted antibiofilm and antibacterial activities against Pseudomonas aeruginosa: A novel biotic therapy. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 14 Issue Pages: 1152588 Pub: 2023 Epub: 2023 Jun 15 Authors Drumond MM , Tapia-Costa AP , Neumann E , Nunes ÁC , Barbosa JW , Kassuha DE , Mancha-Agresti P , |
|
|
Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice. ✅
Go to Publication ✅
Journal of biomedical science (J Biomed Sci ) Vol: 30 Issue 1 Pages: 57 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Chen CM , Yang YSH , Chou HC , Lin S , |
|
|
Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice. ✅
Go to Publication ✅
Journal of biomedical science (J Biomed Sci ) Vol: 30 Issue 1 Pages: 57 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Chen CM , Yang YSH , Chou HC , Lin S , |
|
|
Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice. ✅
Go to Publication ✅
Journal of biomedical science (J Biomed Sci ) Vol: 30 Issue 1 Pages: 57 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Chen CM , Yang YSH , Chou HC , Lin S , |
|
|
Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice. ✅
Go to Publication ✅
Journal of biomedical science (J Biomed Sci ) Vol: 30 Issue 1 Pages: 57 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Chen CM , Yang YSH , Chou HC , Lin S , |
|
|
Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice. ✅
Go to Publication ✅
Journal of biomedical science (J Biomed Sci ) Vol: 30 Issue 1 Pages: 57 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Chen CM , Yang YSH , Chou HC , Lin S , |
|
|
Anti-inflammatory effects of Lactobacillus johnsonii L531 in a pig model of Salmonella Infantis infection involves modulation of CCR6(+) T cell responses and ER stress. ✅
Go to Publication ✅
Veterinary research (Vet Res ) Vol: 51 Issue 1 Pages: 26 Pub: 2020 Feb 24 Epub: 2020 Feb 24 Authors Yang GY , Xia B , Su JH , He T , Liu X , Guo L , Zhang S , Zhu YH , Wang JF , |
|
|
Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell wall. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 11510 Pub: 2020 Jul 13 Epub: 2020 Jul 13 Authors Charlet R , Bortolus C , Sendid B , Jawhara S , |
|
|
Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell wall. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 11510 Pub: 2020 Jul 13 Epub: 2020 Jul 13 Authors Charlet R , Bortolus C , Sendid B , Jawhara S , |
|
|
Bacteroides thetaiotaomicron and Lactobacillus johnsonii modulate intestinal inflammation and eliminate fungi via enzymatic hydrolysis of the fungal cell wall. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 10 Issue 1 Pages: 11510 Pub: 2020 Jul 13 Epub: 2020 Jul 13 Authors Charlet R , Bortolus C , Sendid B , Jawhara S , |
|
|
Use of Lactobacillus johnsonii in broilers challenged with Salmonella sofia. ✅
Go to Publication ✅
Animal nutrition (Zhongguo xu mu shou yi xue hui) (Anim Nutr ) Vol: 1 Issue 3 Pages: 203-212 Pub: 2015 Sep Epub: 2015 Aug 22 Authors Olnood CG , Beski SSM , Choct M , Iji PA , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
